SUMMARY We examined all available data on HLA-A and -B antigen distributions in patients with Crohn's disease and ulcerative colitis. The risk of Crohn's disease was significantly increased in individuals with HLA-A2, having a relative risk of 1 25, in 730 pooled Caucasoid patients compared with 10 863 pooled controls, and decreased in individuals with HLA-A11, having a relative risk of 0O62. The risk of ulcerative colitis was also significantly increased in individuals with HLA-B27 and -Bw35, having a relative risk of 1-81 and 1.41 respectively, in 560 pooled Caucasoid patients compared with 6151 pooled controls, whilst in 144 pooled Japanese patients who were compared with 442 pooled controls, the risk of colitis was increased in individuals with HLA-B5 with a relative risk of 2-79. All differences remained significant after correction for the number of antigens examined. The bases for these genetic associations are unclear.
Analysis of possible associations between individual genetic factors, such as blood groups, and disease have been hindered by two important difficulties. It has not usually been possible to derive any satisfactory hypothesis for investigation and consequentially data have been examined simply because they were available for assessment. Consequently if distributional variations were detected, no knowledge existed about a mechanism to explain them.
Secondly, multiple factors have often been examined simultaneously with a correspondingly increased likelihood that the play of chance events would throw up extreme variations. Problems have been compounded by the tendency for investigators to present the results obtained in small series of individuals without further searches to determine if concordant patterns could be obtained in other series. These difficulties are illustrated by studies of the differential distribution of HLA antigens in healthy controls and in patients with inflammatory bowel disease. Series of patients examined have been small and appropriate corrections to take account of multiple inference within series of data have not Address for correspondence: Professor M J S Langman, University Department of Therapeutics, Queen's Medical Centre, Nottingham, NG7 2UH.
Received for publication 13 December 1985 always been applied. It is therefore not surprising that conflicting results have been often obtained. As a result, a variety of claims of significant deviations from expected values have been made.
Statistical techniques exist which allow one to aggregate sets of data of different sizes, to carry out appropriate weighting and then to derive a single figure to express the relative risk of developing a disease. We have now applied such a technique to published data concerned with the distribution of the HLA antigens in ulcerative colitis and Crohn's disease. In using the probability values corresponding to the x2 for the combined risks, it is inevitable that multiple statistical inference will increase the chance of type I error, claiming a difference to be true when in fact it represents chance variation. Therefore probability values less than 0-05 have been multiplied by the number of comparisons23 -that is, the number of antigens in each segregant series.24 This correction simultaneously increases the chance of type II error, claiming that no true difference exists when there is in fact one. Whenever more than one probability value was lower than 0 05, the sum of all j2s of the combined risk was evaluated taking the number of antigens equal to the number of degrees of freedom, to determine whether the overall distribution of antigens in the patients differed significantly from that in the controls.24
Methods
Results
CROHN'S DISEASE IN CAUCASIANS
In total 730 patients were compared with 10 863 controls ( Table 2 ). As shown in Table 3 , HLA-A2 is positively associated (X2=8-05, Pcorr.=004, relative risk=1.25) and HLA-A11 is negatively associated (x2=11-27, Pcorr.=0 007, relative risk=0-62) with Crohn's disease. The sum of all X2s for combined relative risks was large (25.49 ) and with eight degrees of freedom, one for each of the antigens tested, significant (p<001), but this compound statistic showed no significance when the x2s of A2 and 11 were excluded, confirming that the association of these antigens with Crohn's disease is likely to be valid. None of the individual HLA-A antigen series were significantly heterogeneous, thus the combined relative risks of A2 and 11 are not significantly in contradiction to the relative risks found in the individual data sets.
Examination of the data for the HLA-B antigens revealed no less than six significant associations. The combined relative risk was greater than one for the antigens B14, 15, 18, w21 and 37, while the combined relative risk of B8 was less than one. By correction for the number of antigens, however, only one association -that is, B18, remained significant (X2=11626, Pcorr. <0*001, relative risk=1*72).
The sum of x2S for combined relative risk was significantly increased (X2=59 98, p<0001) and remained increased if data for B18 were removed, indicating that some of the residual differences for individual antigens which appear insignificant after correction for total antigen numbers may in fact The x2 for heterogeneity was significant for B12 and 18, indicating great variation of relative risks between individual series. Comparing the relative risks of the individual series with the combined relative risk for B12 and 18 according to Bodmer et al,22 we found the combined relative risk of B12 significantly different from the relative risks found in the studies in Australia,' Sweden7 and Nottingham, UK,10 whilst the combined relative risk of B18 deviated significantly from the relative risks found in the studies in Amsterdam,4 and Birmingham.8 As the combined relative risk is the weighted mean of the individual relative risks, the individual series containing most patients and controls contributes most to the combined relative risk; so if the x2 for the heterogeneity is significant another factor becomes important, namely the number of patients and controls in the individual series. As this is an uncontrolled variable, the combined relative risk says nothing in this case. Taken overall, these findings suggest that there are large unexplained variations in the distribution of HLA-B antigens in Crohn's disease from one series to another.
ULCERATIVE COLITIS IN CAUSASIANS
Five hundred and sixty patients with ulcerative colitis from Caucasoid origin were compared with 6151 healthy controls ( Table 4 ). As shown in Table 5 none of the HLA-A antigens were found to be associated with this disease, although there was significant heterogeneity for HLA-A10, probably caused by the low frequency of this antigen in the controls in the Dutch study from Amsterdam, NL4 as compared with frequency of this antigen in the Dutch population as reported in the Histocompatibility Workshop in 1980. 19 Three HLA-B antigens, 13, 27, and w35 were found to be positively associated with ulcerative colitis, although only two were significant after correction for the number of antigens -that is, B27 (x2= 16X50, Pcorr.=0-001, relative risk= 1.81) and Bw35 (x2=9*7, Pcorr.=0.03, relative risk=1.41). The total sum of x2S for the combined risks was significant for 16 degrees of freedom (X2=38-9, p<O01), but exclusion of B27 and w35 resulted in loss of significance of this statistic, suggesting that the apparent association of B13 could be the result of the play of chance. None of the HLA-B antigen results from individual centres were significantly One hundred and forty four Japanese patients suffering from ulcerative colitis and 442 healthy Japanese controls have been compared (Table 4) . As shown in Table 6 , none of the HLA-A antigens were associated with ulcerative colitis; Awl9 gave significant heterogeneity but this can be explained by the low frequency of w19 in the study of Asakura et al15 as compared with the frequency reported in the Histocompatibility Workshop in 1980.19 The HLA-B locus showed a highly significant association with HLA-B5 (X2=24-78, Pcorr. <0*001, relative risk=2.79) and this finding was consistent in all studies because all X2s for heterogeneity were low.
Discussion
The analysis of individual sets of data has suggested variously that liability to Crohn's disease and ulcerative colitis might be associated with a variety of antigens (Table 7) . Acceptance of these findings is hindered by the small size of the individual sets of data, and generally modest levels of significance detected, sometimes in the apparent absence of corrections to take account of the multiple antigens examined and their relative distributions in test and control subjects.
After considering the results of a large number of sets of patient-control studies, we have found that Caucasians who are HLA-A11 appear to have a relative risk of about 0*62 and those who are HLA-A2 a relative risk of 1 25 to develop Crohn's disease (Table 5) . In Japanese quite another association was found. HLA-B5 individuals appear to have a relative risk of 2-79 to develop ulcerative colitis, while no association is found with HLA-B27 (Table 6 ). This last result is not surprising given that HLA-B27 is very rare in the Japanese.
We cannot easily explain these findings. HLA-B27 is known to be strongly associated with liability to ankylosing spondylitis, and we might have detected an apparent association if a significant proportion of our colitic series were originally ascertained because they already had ankylosing spondylitis. In none of the series which we have examined, however, did such ascertainment seem to have occurred, and if it had been the cause of spurious association we would have expected the same to hold true for Crohn's disease, whereas the relative risk there associated with HLA-B27 was close to unity.
The mathematical techniques we have used take pairs of test and control series which are considered individually and then weighted according to their total size before an overall relative risk is calculated. Such a method clearly could not throw up a spurious overall correlation, though it could conceal a real association which was present; say in patients developing the disease in a single specific area. One check for between series variability is given by considering their heterogeneity statistically. Significant heterogeneity was detected for Crohn's disease and the cause is not clear. One possible reason could be that series were collated at different times in different places, and control data may not necessarily have been collated simultaneously. Antisera may not necessarily have been of equivalent potency, and the range available could have varied and such factors could have contributed to heterogeneity.
We conclude that an individual's HLA-A or -B status appears to influence liability to Crohn's disease and ulcerative colitis. The relative risks associated with HLA-A or -B antigens are at least as large as those associated with ABO blood group and secretor status, and liability to peptic ulcer and its complications.25 Evaluating the population attributable risk as measure for the rate of the disease in individuals having a certain antigen that can be attributed to that antigen,26 we found that HLA-B5 contributes 42% to ulcerative colitis in the Japanese, while in Caucasians HLA-A2 contributes no more than 11% to Crohn's disease and this figure is for the other associations even lower.
As the contribution is small, other markers within the HLA system should be looked for and special emphasis should be made in defining subgroups of patients to assess more fully the contribution of HLA to chronic inflammatory bowel diseases.
